Month: August 2020

Second Quarter GAAP Loss of $10 Million or $0.14 Per Share Including Anticipated Acquisition, Integration and Financing Costs; Adjusted Earnings Per Share of $0.13Adjusted EBITDA Totaled $59 Million, Highlighting Positive Operational and Cost Performance While Facing COVID-19 Headwinds, as Well as Timing of Expenditures and Acquisition Contributions Net Cash Provided by Operating Activities of $33 Million in Q2; Free Cash Flow Totaled $18 Million Driven by Actions to Lower Capital Spending as Well as Working Capital Initiatives Company Net Leverage Ratio of 3.9x and Liquidity Position Exceeded $390 Million at Quarter-End Business Continuity Actions In Response to COVID-19 Driving Significant Cost Reductions;  Company Remains Committed to Lower Capital Spending and Positive Free Cash FlowCAMP HILL, Pa., Aug. 05, 2020 (GLOBE NEWSWIRE) —...

ROCKFORD, Mich., Aug. 05, 2020 (GLOBE NEWSWIRE) — Wolverine World Wide, Inc. (NYSE: WWW) today reported  financial results for the second quarter ended June 27, 2020, that significantly exceeded its expectations across every key financial metric and provided an update on initiatives implemented to navigate the COVID-19 pandemic.“The Company’s second quarter results were much stronger than expected, despite the negative impact of unprecedented global market conditions and significant retail store closures for much of the time period,” said Blake W. Krueger, Wolverine Worldwide’s Chairman, Chief Executive Officer and President.  “Our brands excelled online, with nearly triple-digit owned eCommerce revenue growth, benefiting from strength in key product categories that are resonating with consumers and the digital capabilities...

Heidelberg, Germany, August 5, 2020 – Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced the appointments of Dr. Annalisa Jenkins and Mr. Harry Welten to its Supervisory Board.  Both these appointments were approved during the Annual General Meeting of Shareholders which took place on August 4, 2020.“Affimed is pleased to welcome Annalisa and Harry, both highly experienced professionals in their respective fields, to the Supervisory Board” said Dr. Thomas Hecht, Chairman of Affimed’s Supervisory Board. “Annalisa is a visionary leader who knows how to translate science from bench to bedside.  Harry is an accomplished financial executive who is well suited to help drive value-creating strategies for the company.  Together, these new...

DALLAS, Aug. 05, 2020 (GLOBE NEWSWIRE) — Blucora, Inc. (NASDAQ: BCOR), a provider of data and technology-driven tax software and wealth management solutions that empowers people to improve their financial wellness, today announced financial results for the second quarter ended June 30, 2020.Second Quarter and Tax Season Highlights and Recent DevelopmentsTaxAct grows total e-files (consumer + professional) by 1% year-over-year, amid extended tax season (due to COVID-19), with consumer e-files declining 2% and professional e-files growing by 6%.Improved several key business metrics for tax season, including unique visitors, retention and conversion rates and net promoter score.Tax preparation revenue expected to decline approximately 3% for the full-year 2020 compared to the full-year 2019. Full-year 2019 tax preparation revenue included...

ENDEAVOUR REPORTS Q2-2020 RESULTSOn track to meet FY-2020 guidance  · Significant improvement in leverage ratio  · Dividend initiation approaching HIGHLIGHTS Production of 149koz at an AISC of $939/oz in Q2-2020; Production of 321koz at an AISC of $918/oz in H1-2020Integration process is largely complete with the SEMAFO assets slotted into Endeavour’s well-established West African operating modelOn track to achieve full year production and AISC guidance for both Endeavour and SEMAFO assets despite COVID-19, resulting in a Pro Forma guidance of 995—1,095koz at an AISC of $865—915/ozOperating Cash Flow before Working Capital of $85m or $0.77/share for Q2-2020; $205m or $1.85/share for H1-2020Adjusted Net Earnings of $53m or $0.48/share in Q2-2020; $86m or $0.78/share in H1-2020Strong deleveraging as Net Debt / Adjusted EBITDA ratio...

Kinnevik AB (publ) (“Kinnevik”) today announced that it supports the proposed merger between Teladoc Health, Inc. (NYSE: TDOC) (“Teladoc Health”), the global leader in virtual care, and Livongo Health, Inc. (Nasdaq: LVGO) (“Livongo”), the leading Applied Health Signals company, creating the only consumer centered virtual care platform for a full spectrum of health needs. When the merger has been completed, Kinnevik will become an owner of a 4.5 percent stake in the combined company and receive USD 143m (SEK 1.3bn) in cash consideration. The merger consideration values Kinnevik’s stake in Livongo at approximately USD 2.0bn (SEK 17.6bn), up USD 183m (SEK 1.6bn) from the value of Kinnevik’s stake in Livongo at 4 August 2020 close.As announced today by Teladoc Health and Livongo, the companies have entered into an agreement to merge....

Kinnevik AB (publ) (“Kinnevik”) meddelade idag att bolaget stödjer den föreslagna fusionen mellan Teladoc Health, Inc. (NYSE: TDOC) (“Teladoc Health”), den ledande globala aktören inom digital vård, och Livongo Health, Inc. (Nasdaq: LVGO) (“Livongo”), det ledande bolaget inom Applied Health Signals, vilket skapar den enda konsumentcentrerade digitala vårdplattformen som täcker ett brett spektrum av vårdbehov. När fusionen har genomförts kommer Kinnevik att bli ägare till 4,5 procent i det kombinerade bolaget, och erhålla 143 MUSD (1,3 Mdkr) i kontantvederlag. Fusionsvederlaget värderar Kinneviks innehav i Livongo till cirka 2,0 MdUSD (17,6 Mdkr) vilket motsvarar en ökning om 183 MUSD (1,6 Mdkr) jämfört med värdet på Kinneviks innehav i Livongo baserat på stängningskursen den 4 augusti 2020.Teladoc Health och Livongo meddelade idag att...

The Company’s application for delisting its common shares from the Oslo Stock Exchange (the “OSE”) was today approved by the OSE.According to the OSE resolution, the shares in Team Tankers International Ltd. will be delisted from the Oslo Stock Exchange from 1 October 2020. The last day of listing will be 30 September 2020. The Board of DirectorsTeam Tankers International Ltd.Hamilton, Bermuda Questions should be directed to:Hans Feringa: President and CEOT: +1 203 341 3600 Jens Gisle Schnelle: CFOT: +1 203 341 3600 About Team Tankers InternationalTeam Tankers International Ltd. is a leading tanker company committed to providing safe, reliable and incident free transport services to our worldwide customer base. The Company transports a wide variety of cargoes including organic chemicals, non-organic chemicals, petroleum...

The only consumer centered virtual care platform for full spectrum of health needs to address accelerating consumer and client demand   Combination of highly complementary leaders in virtual care and chronic condition management uniquely positioned to unlock the full potential of virtual care New high-quality care delivery model creates new category of solutions focused on delivering unrivaled whole-person care for better health outcomes at lower cost Significant quantifiable revenue expansion opportunities increase shareholder value as two of the fastest-growing companies in healthcare technology combinePURCHASE, NY and MOUNTAIN VIEW, Calif., Aug. 05, 2020 (GLOBE NEWSWIRE) — Teladoc Health (TDOC), the global leader in virtual care, and Livongo (LVGO), the leading Applied Health Signals company – today announced that they have entered...

Second quarter total revenue of $91.9 million, up 125% year-over-yearOver 410,000 enrolled Livongo for Diabetes Members, up 113% year-over-yearMOUNTAIN VIEW, Calif., Aug. 05, 2020 (GLOBE NEWSWIRE) — Livongo Health, Inc. (NASDAQ: LVGO), the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced financial results for its second quarter ended June 30, 2020.“Livongo entered 2020 with significant momentum and our strong results continued during the second quarter,” said Zane Burke, Chief Executive Officer of Livongo.  “Innovative employers and health plans are choosing Livongo due to our leading Consumer Directed Virtual Care model and our ability to deliver significant clinical and financial improvements through a one-to-many approach. As we experience the...